J Clin Invest. 2008 Jun;118(6):1979-90.

To kill a tumor cell: the potential of proapoptotic receptor agonists.

Source

Genentech, South San Francisco, California 94080, USA. aa@gene.com

Abstract

Disturbances in mechanisms that direct abnormal cells to undergo apoptosis frequently and critically contribute to tumorigenesis, yielding a logical target for potential therapeutic intervention. There is currently heightened interest in the extrinsic apoptosis pathway, with several proapoptotic receptor agonists (PARAs) in development. The PARAs include the ligand recombinant human Apo2L/TRAIL and agonistic mAbs. Mechanistic and preclinical data with Apo2L/TRAIL indicate exciting opportunities for synergy with conventional therapies and for combining PARAs with other molecularly targeted agents. Novel molecular biomarkers may help identify those patients most likely to benefit from PARA therapy.

PMID:: 18523647; [PubMed - indexed for MEDLINE]
PMCID:: PMC2396896

Free PMC Article

Images from this publication.See all images (1) Free text

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Save items

Related citations in PubMed

Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11. [Cancer Res. 2003]
Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
Ray S, Almasan A. Cancer Res. 2003 Aug 1; 63(15):4713-23.
The essential role of the mitochondria-dependent death-signaling cascade in chemotherapy-induced potentiation of Apo2L/TRAIL cytotoxicity in cultured thoracic cancer cells: amplified caspase 8 is indispensable for combination-mediated massive cell death. [Cancer J. 2006]
The essential role of the mitochondria-dependent death-signaling cascade in chemotherapy-induced potentiation of Apo2L/TRAIL cytotoxicity in cultured thoracic cancer cells: amplified caspase 8 is indispensable for combination-mediated massive cell death.
Nguyen DM, Yeow WS, Ziauddin MF, Baras A, Tsai W, Reddy RM, Chua A, Cole GW Jr, Schrump DS. Cancer J. 2006 Jul-Aug; 12(4):257-73.
Physiological and molecular effects of Apo2L/TRAIL and cisplatin in ovarian carcinoma cell lines. [Cancer Lett. 2003]
Physiological and molecular effects of Apo2L/TRAIL and cisplatin in ovarian carcinoma cell lines.
Siervo-Sassi RR, Marrangoni AM, Feng X, Naoumova N, Winans M, Edwards RP, Lokshin A. Cancer Lett. 2003 Feb 10; 190(1):61-72.
Review Proapoptotic DR4 and DR5 signaling in cancer cells: toward clinical translation. [Curr Opin Cell Biol. 2010]
Review Proapoptotic DR4 and DR5 signaling in cancer cells: toward clinical translation.
Yang A, Wilson NS, Ashkenazi A. Curr Opin Cell Biol. 2010 Dec; 22(6):837-44. Epub 2010 Aug 31.
Review Death receptor agonists as a targeted therapy for cancer. [Clin Cancer Res. 2010]
Review Death receptor agonists as a targeted therapy for cancer.
Wiezorek J, Holland P, Graves J. Clin Cancer Res. 2010 Mar 15; 16(6):1701-8. Epub 2010 Mar 2.

See reviews... See all...

Cited by 38 PubMed Central articles

Activating Death Receptor DR5 as a Therapeutic Strategy for Rhabdomyosarcoma. [ISRN Oncol. 2012]
Activating Death Receptor DR5 as a Therapeutic Strategy for Rhabdomyosarcoma.
Kang Z, Sun SY, Cao L. ISRN Oncol. 2012; 2012:395952. Epub 2012 Apr 17.
Targeting different types of human meningioma and glioma cells using a novel adenoviral vector expressing GFP-TRAIL fusion protein from hTERT promoter. [Cancer Cell Int. 2011]
Targeting different types of human meningioma and glioma cells using a novel adenoviral vector expressing GFP-TRAIL fusion protein from hTERT promoter.
Li JT, Bian K, Zhang AL, Kim DH, Ashley WW, Nath R, McCutcheon I, Fang B, Murad F. Cancer Cell Int. 2011 Oct 28; 11(1):35. Epub 2011 Oct 28.
Review Platinum resistance in breast and ovarian cancer cell lines. [J Exp Clin Cancer Res. 2011]
Review Platinum resistance in breast and ovarian cancer cell lines.
Eckstein N. J Exp Clin Cancer Res. 2011 Oct 4; 30:91. Epub 2011 Oct 4.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

To kill a tumor cell: the potential of proapoptotic receptor agonists.
To kill a tumor cell: the potential of proapoptotic receptor agonists.
J Clin Invest. 2008 Jun ;118(6):1979-90.

PubMed
Agrobacterium tumefaciens-induced bacteraemia does not lead to reporter gene exp...
Agrobacterium tumefaciens-induced bacteraemia does not lead to reporter gene expression in mouse organs.
PLoS One. 2008 Jun 4 ;3(6):e2352.

PubMed
The three princes of Serendip: notes on a mysterious phenomenon.
The three princes of Serendip: notes on a mysterious phenomenon.
Mcgill J Med. 2006 Jul ;9(2):161-3.

PubMed
Asbestos: mining exposure, health effects and policy implications.
Asbestos: mining exposure, health effects and policy implications.
Mcgill J Med. 2007 Jul ;10(2):121-6.

PubMed
Yeast mitochondrial biogenesis: a role for the PUF RNA-binding protein Puf3p in ...
Yeast mitochondrial biogenesis: a role for the PUF RNA-binding protein Puf3p in mRNA localization.
PLoS One. 2008 Jun 4 ;3(6):e2293.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

To kill a tumor cell: the potential of proapoptotic receptor agonists.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Save items

Related citations in PubMed

Cited by 38 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information